✦ LIBER ✦

Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-α synthesis

✍ Scribed by Tim F. Greten; Bhanu Sinha; Christiane Haslberger; Andreas Eigler; Stefan Endres

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The specific type IV phosphodiesterase i

✍ J. Semmler; H. Wachtell; S. Endres 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 374 KB

The specific type III and IV phosphodies

✍ F. Ulrich Schade; Christian Schudt 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 527 KB

Prevention of EAE in non-human primates

✍ C.P. Genain; M.H. Nguyen; D. Faulds; A. Uccelli; R.L. Davis; J. Hedgpeth; S.L. H 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 144 KB

The effects of phosphodiesterase type 4

✍ Christine Brideau; Carlo Van Staden; Angela Styhler; Ian W Rodger; Chi-Chung Cha 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 374 KB

Synthesis and in vitro profile of a nove

✍ John B. Cheng; Kelvin Cooper; Allen J. Duplantier; James F. Eggler; Kenneth G. K 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 177 KB

DNase I hypersensitive sites in the 5′ f

✍ Donna Mahony; Brett W. Stringer; Joanne L. Dickinson; Toni M. Antalis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB